Endothelial Snai1 inhibition improved the tumor vasculature, with respect to all three parameters—a stark contrast to anti-VEGFA therapy that only improves vessel maturation but often reduces the already critical vessel density even further. The gene discussed is SNAI1; the disease is neoplasm.